Cadrenal Therapeutics (CVKD) Non Operating Interest Expenses (2022 - 2023)
Cadrenal Therapeutics' (CVKD) quarterly Non Operating Interest Expenses came in at -$969801.0 in Q2 2023, down 15145.0% year-over-year from N/an in Q2 2022, and down 199.64% quarter-over-quarter from $973335.0 in Q1 2023.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Non Operating Interest Expenses (2022 - 2023) Analysis & Trends
Cadrenal Therapeutics has disclosed Non Operating Interest Expenses across 2 years of filings, most recently posting -$969801.0 for Q2 2023.
- In Q2 2023, Non Operating Interest Expenses fell 15145.0% year-over-year to -$969801.0; the TTM figure through Sep 2023 stood at $4.0 million (changed N/A YoY), while the FY2022 annual figure was $4.0 million, changed N/A from the prior year.
- Non Operating Interest Expenses came in at -$969801.0 for Q2 2023 at Cadrenal Therapeutics, down from $973335.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $4.0 million in Q4 2022 to a low of -$969801.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -333.60 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 23.78 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 582,000.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 2.90 Mn |
| 10 | Cadrenal Therapeutics | 3.55 Mn | 1.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -969,801.00 |
| Mar 31, 2023 | 973,335.00 |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 13,544.00 |
| Jun 30, 2022 | 6,446.00 |
| Mar 31, 2022 | 6,127.00 |